Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Regeneron Pharmaceuticals - 33 Year Stock Price History | REGN

Historical daily share price chart and data for Regeneron Pharmaceuticals since 1991 adjusted for splits and dividends. The latest closing stock price for Regeneron Pharmaceuticals as of April 25, 2024 is 890.68.
  • The all-time high Regeneron Pharmaceuticals stock closing price was 993.35 on February 27, 2024.
  • The Regeneron Pharmaceuticals 52-week high stock price is 998.33, which is 12.1% above the current share price.
  • The Regeneron Pharmaceuticals 52-week low stock price is 684.80, which is 23.1% below the current share price.
  • The average Regeneron Pharmaceuticals stock price for the last 52 weeks is 840.43.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Regeneron Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 943.6445 905.0000 993.3500 890.6800 890.6800 1.41%
2023 783.8250 720.4700 881.7000 680.4900 878.2900 21.73%
2022 662.5164 627.1000 766.3900 548.3500 721.4900 14.25%
2021 558.3248 482.8600 680.9600 446.7300 631.5200 30.72%
2020 532.3580 373.3500 658.2100 336.1800 483.1100 28.66%
2019 343.5064 372.4400 439.5700 273.4600 375.4800 0.53%
2018 351.6680 382.6000 408.5100 284.6000 373.5000 -0.65%
2017 422.4830 379.7000 526.5300 340.7500 375.9600 2.42%
2016 394.5000 516.5500 519.4800 331.0500 367.0900 -32.38%
2015 498.7331 410.1600 592.4000 396.8900 542.8700 32.33%
2014 333.6675 274.5900 434.9500 267.6200 410.2500 49.05%
2013 239.8612 181.2000 316.6320 158.4200 275.2400 60.89%
2012 130.8339 56.4300 187.7400 56.4300 171.0700 208.62%
2011 51.1067 33.8200 72.1900 32.6100 55.4300 68.84%
2010 26.2129 24.6300 33.6900 20.7900 32.8300 35.77%
2009 17.7172 18.7000 24.7400 12.0500 24.1800 31.70%
2008 18.9787 23.5600 24.7500 13.3500 18.3600 -23.98%
2007 20.5494 19.8100 28.6000 13.6600 24.1500 20.33%
2006 16.1155 15.9000 24.2800 11.1200 20.0700 26.23%
2005 8.2982 9.0400 16.8300 4.6300 15.9000 72.64%
2004 10.8352 15.0500 16.7200 6.8500 9.2100 -37.39%
2003 14.7557 19.0900 22.3050 5.8800 14.7100 -20.53%
2002 18.8848 27.9200 29.3100 11.3600 18.5100 -34.27%
2001 28.3779 35.5600 39.0000 20.6000 28.1600 -20.16%
2000 27.3401 12.3100 56.5000 11.6300 35.2700 176.63%
1999 7.8169 7.9380 12.7500 5.5630 12.7500 72.88%
1998 8.1477 8.8750 10.9400 5.8750 7.3750 -13.87%
1997 9.8900 17.1300 19.3800 6.5000 8.5630 -46.88%
1996 16.2382 13.2500 24.6250 11.8750 16.1200 26.43%
1995 9.5972 3.3130 16.9400 3.3130 12.7500 325.00%
1994 7.0362 15.2500 17.2500 3.0000 3.0000 -80.65%
1993 15.5031 12.0000 21.5000 11.0000 15.5000 29.17%
1992 13.0192 18.7500 22.5000 8.0000 12.0000 -33.81%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $99.504B $13.117B
Regeneron is a biotechnology company focused on the discovery, development and commercialization of treatments targeting serious medical conditions. The company's portfolio boasts nine marketed drugs - Eylea, Dupixent, Praluent, Kevzara, Libtayo, Evkeeza, Inmazeb Arcalyst and Zaltrap. The company also developed an antibody cocktail for COVID-19, REGEN-COV. REGEN-COV is a cocktail of two monoclonal antibodies and was designed specifically to block the infectivity of SARS-CoV-2, the virus that causes COVID-19. Regeneron has a collaboration agreement with Roche for the same. While Regeneron has co-developed Eylea with Bayer's HealthCare unit, Praluent was co-developed with Sanofi. Regeneron collaborated with Bayer for the joint development and commercialization of co-formulated combinations of Eylea, rinucumab and nesvacumab for the treatment of ocular diseases or disorders outside the United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $146.436B 14.64
Vertex Pharmaceuticals (VRTX) United States $103.580B 29.82
Bristol Myers Squibb (BMY) United States $99.027B 6.51
CSL (CSLLY) Australia $87.082B 0.00
GSK (GSK) United Kingdom $84.680B 10.61
Gilead Sciences (GILD) United States $83.520B 9.98
Moderna (MRNA) United States $41.676B 0.00
Biogen (BIIB) United States $29.361B 13.47
Argenex SE (ARGX) Netherlands $22.287B 0.00
BioNTech SE (BNTX) Germany $20.941B 21.38
Illumina (ILMN) United States $19.568B 141.23
Genmab (GMAB) Denmark $18.825B 24.13
Alnylam Pharmaceuticals (ALNY) United States $18.111B 0.00
BioMarin Pharmaceutical (BMRN) United States $17.213B 67.56
BeiGene (BGNE) Cayman Islands $13.784B 0.00
Sarepta Therapeutics (SRPT) United States $11.667B 0.00
Incyte (INCY) United States $11.617B 19.31
Exact Sciences (EXAS) United States $11.480B 0.00
Bio-Techne Corp (TECH) United States $9.985B 37.15
QIAGEN (QGEN) Netherlands $9.475B 19.61
Repligen (RGEN) United States $9.373B 97.03
Roivant Sciences (ROIV) United Kingdom $8.784B 0.00
Ascendis Pharma (ASND) Denmark $8.337B 0.00
Legend Biotech (LEGN) United States $8.217B 0.00
Bio-Rad Laboratories (BIO.B) United States $7.983B 23.78
Viking Therapeutics (VKTX) United States $7.172B 0.00
Intra-Cellular Therapies (ITCI) United States $7.079B 0.00
Exelixis (EXEL) United States $6.990B 37.05
Cytokinetics (CYTK) United States $6.988B 0.00
Vaxcyte (PCVX) United States $6.558B 0.00
Apellis Pharmaceuticals (APLS) United States $6.021B 0.00
Blueprint Medicines (BPMC) United States $5.646B 0.00
Halozyme Therapeutics (HALO) United States $4.970B 15.34
CRISPR Therapeutics AG (CRSP) Switzerland $4.724B 0.00
Krystal Biotech (KRYS) United States $4.535B 0.00
Zealand Pharma (ZLDPF) Denmark $4.494B 0.00
Nuvalent (NUVL) United States $4.305B 0.00
Immunovant (IMVT) United States $4.184B 0.00
Alkermes (ALKS) Ireland $4.170B 22.01
Insmed (INSM) United States $3.834B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.644B 0.00
Biohaven (BHVN) United States $3.417B 0.00
Axsome Therapeutics (AXSM) United States $3.372B 0.00
Fortrea Holdings (FTRE) United States $3.329B 0.00
Iovance Biotherapeutics (IOVA) United States $3.271B 0.00
ImmunityBio (IBRX) United States $3.263B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.208B 0.00
SpringWorks Therapeutics (SWTX) United States $3.201B 0.00
Amicus Therapeutics (FOLD) United States $3.113B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.980B 0.00
IDEAYA Biosciences (IDYA) United States $2.979B 0.00
Immunocore Holdings (IMCR) United Kingdom $2.913B 0.00
Arcellx (ACLX) United States $2.815B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.734B 0.00
Apogee Therapeutics (APGE) United States $2.720B 0.00
MorphoSys AG (MOR) Germany $2.719B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.711B 0.00
Certara (CERT) United States $2.635B 56.72
Janux Therapeutics (JANX) United States $2.491B 0.00
Merus (MRUS) Netherlands $2.463B 0.00
CG Oncology (CGON) United States $2.402B 0.00
Rhythm Pharmaceuticals (RYTM) United States $2.388B 0.00
Vericel (VCEL) United States $2.231B 0.00
Arvinas (ARVN) United States $2.223B 0.00
Denali Therapeutics (DNLI) United States $2.218B 0.00
Guardant Health (GH) United States $2.203B 0.00
Vera Therapeutics (VERA) United States $2.175B 0.00
Kymera Therapeutics (KYMR) United States $2.152B 0.00
Rocket Pharmaceuticals (RCKT) United States $2.139B 0.00
Celldex Therapeutics (CLDX) United States $2.069B 0.00
Intellia Therapeutics (NTLA) United States $2.042B 0.00
Keros Therapeutics (KROS) United States $2.028B 0.00
Avidity Biosciences (RNA) United States $2.000B 0.00
Geron (GERN) United States $1.958B 0.00
Galapagos (GLPG) Belgium $1.896B 0.00
Sana Biotechnology (SANA) United States $1.891B 0.00
Beam Therapeutics (BEAM) United States $1.872B 0.00
Ginkgo Bioworks Holdings (DNA) United States $1.821B 0.00
NeoGenomics (NEO) United States $1.791B 0.00
Twist Bioscience (TWST) United States $1.778B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.766B 0.00
Structure Therapeutics (GPCR) United States $1.698B 0.00
Myriad Genetics (MYGN) United States $1.686B 0.00
Bavarian Nordic (BVNRY) Denmark $1.675B 5.50
Harmony Biosciences Holdings (HRMY) United States $1.660B 13.79
Inhibrx (INBX) United States $1.629B 0.00
Zai Lab (ZLAB) China $1.554B 0.00
Neumora Therapeutics (NMRA) United States $1.524B 0.00
Edgewise Therapeutics (EWTX) United States $1.500B 0.00
Protagonist Therapeutics (PTGX) United States $1.498B 0.00
Dynavax Technologies (DVAX) United States $1.494B 0.00
ADMA Biologics Inc (ADMA) United States $1.474B 0.00
Kura Oncology (KURA) United States $1.428B 0.00
Arcus Biosciences (RCUS) United States $1.403B 0.00
Akero Therapeutics (AKRO) United States $1.401B 0.00
Morphic Holding (MORF) United States $1.386B 0.00
ANI Pharmaceuticals (ANIP) United States $1.379B 16.95
Gyre Therapeutics (GYRE) United States $1.371B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.327B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.261B 0.00
Ligand Pharmaceuticals (LGND) United States $1.257B 15.57
Verona Pharma American Depositary Share (VRNA) United Kingdom $1.232B 0.00
Spyre Therapeutics (SYRE) United States $1.193B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.181B 0.00
AbCellera Biologics (ABCL) Canada $1.142B 0.00
MannKind (MNKD) United States $1.134B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.132B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.121B 0.00
Autolus Therapeutics (AUTL) United Kingdom $1.120B 0.00
Prothena (PRTA) Ireland $1.104B 0.00
Scholar Rock Holding (SRRK) United States $1.097B 0.00
Belite Bio (BLTE) United States $1.086B 0.00
Vir Biotechnology (VIR) United States $1.081B 0.00
Abivax SA (ABVX) France $1.000B 0.00
Liquidia Technologies (LQDA) United States $0.954B 0.00
MiMedx (MDXG) United States $0.949B 214.33
Immatics (IMTX) Germany $0.859B 0.00
Immunome (IMNM) United States $0.852B 0.00
Arcutis Biotherapeutics (ARQT) United States $0.847B 0.00
Tyra Biosciences (TYRA) United States $0.840B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.835B 0.00
Tango Therapeutics (TNGX) United States $0.828B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.821B 0.00
Viridian Therapeutics (VRDN) United States $0.818B 0.00
89BIO (ETNB) United States $0.817B 0.00
Cullinan Therapeutics (CGEM) United States $0.814B 0.00
ALX Oncology Holdings (ALXO) United States $0.811B 0.00
REGENXBIO (RGNX) United States $0.787B 0.00
Kyverna Therapeutics (KYTX) United States $0.764B 0.00
PureTech Health (PRTC) United States $0.742B 0.00
Cytek Biosciences (CTKB) United States $0.740B 0.00
CARGO Therapeutics (CRGX) United States $0.738B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.726B 0.00
Pliant Therapeutics (PLRX) United States $0.718B 0.00
Longboard Pharmaceuticals (LBPH) United States $0.711B 0.00
Mesoblast (MESO) Australia $0.710B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.681B 0.00
Praxis Precision Medicines (PRAX) United States $0.677B 0.00
Nurix Therapeutics (NRIX) United States $0.676B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.669B 0.00
Pharming Group (PHAR) Netherlands $0.660B 0.00
Disc Medicine (IRON) United States $0.659B 0.00
EnGene Holdings (ENGN) United States $0.643B 0.00
Dianthus Therapeutics (DNTH) United States $0.626B 0.00
HilleVax (HLVX) United States $0.625B 0.00
Cogent Biosciences (COGT) United States $0.625B 0.00
Pharming Group (PHGUF) Netherlands $0.620B 0.00
WAVE Life Sciences (WVE) Singapore $0.613B 0.00
Stoke Therapeutics (STOK) United States $0.608B 0.00
Cabaletta Bio (CABA) United States $0.607B 0.00
Zymeworks (ZYME) United States $0.603B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.594B 0.00
Aerovate Therapeutics (AVTE) United States $0.591B 0.00
Novavax (NVAX) United States $0.581B 0.00
Nuvation Bio (NUVB) United States $0.580B 0.00
GH Research (GHRS) Ireland $0.576B 0.00
Olema Pharmaceuticals (OLMA) United States $0.568B 0.00
Prime Medicine (PRME) United States $0.564B 0.00
Mineralys Therapeutics (MLYS) United States $0.564B 0.00
CureVac (CVAC) Germany $0.562B 0.00
Northwest Biotherapeutics (NWBO) United States $0.554B 0.00
Castle Biosciences (CSTL) United States $0.545B 0.00
Oric Pharmaceuticals (ORIC) United States $0.544B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.534B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.527B 0.00
Allogene Therapeutics (ALLO) United States $0.519B 0.00
Celcuity (CELC) United States $0.516B 0.00
AnaptysBio (ANAB) United States $0.516B 0.00
ArriVent BioPharma (AVBP) United States $0.512B 0.00
Absci (ABSI) United States $0.512B 0.00
Alector (ALEC) United States $0.503B 0.00
Adlai Nortye (ANL) Cayman Islands $0.500B 0.00
Astria Therapeutics (ATXS) United States $0.494B 0.00
Arbutus Biopharma (ABUS) United States $0.494B 0.00
Applied Therapeutics (APLT) United States $0.492B 0.00
Fate Therapeutics (FATE) United States $0.489B 0.00
Oculis Holding AG (OCS) Switzerland $0.485B 0.00
Shattuck Labs (STTK) United States $0.471B 0.00
IGM Biosciences (IGMS) United States $0.468B 0.00
Third Harmonic Bio (THRD) United States $0.462B 0.00
Humacyte (HUMA) United States $0.455B 0.00
Fulcrum Therapeutics (FULC) United States $0.452B 0.00
ACELYRIN, INC (SLRN) United States $0.452B 0.00
C4 Therapeutics (CCCC) United States $0.444B 0.00
Editas Medicine (EDIT) United States $0.440B 0.00
Avid Bioservices (CDMO) United States $0.432B 0.00
Entrada Therapeutics (TRDA) United States $0.418B 0.00
Travere Therapeutics (TVTX) United States $0.415B 0.00
Voyager Therapeutics (VYGR) United States $0.411B 2.45
Annexon (ANNX) United States $0.401B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.396B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.394B 0.00
MaxCyte (MXCT) United States $0.390B 0.00
Replimune (REPL) United States $0.389B 0.00
Neurogene (NGNE) United States $0.389B 0.00
Biomea Fusion (BMEA) United States $0.387B 0.00
Anika Therapeutics (ANIK) United States $0.385B 0.00
PepGen (PEPG) United States $0.383B 0.00
Alto Neuroscience (ANRO) United States $0.382B 0.00
ITeos Therapeutics (ITOS) United States $0.379B 0.00
Adaptive Biotechnologies (ADPT) United States $0.377B 0.00
FibroBiologics (FBLG) United States $0.376B 0.00
Revance Therapeutics (RVNC) United States $0.372B 0.00
Amarin (AMRN) Ireland $0.361B 0.00
Nkarta (NKTX) United States $0.354B 0.00
Precigen (PGEN) United States $0.353B 0.00
TScan Therapeutics (TCRX) United States $0.353B 0.00
Aura Biosciences (AURA) United States $0.351B 0.00
Rani Therapeutics Holdings (RANI) United States $0.351B 0.00
Mersana Therapeutics (MRSN) United States $0.349B 0.00
Caribou Biosciences (CRBU) United States $0.348B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.347B 0.00
Tenaya Therapeutics (TNYA) United States $0.344B 0.00
Urogen Pharma (URGN) United States $0.333B 0.00
Jasper Therapeutics (JSPR) United States $0.332B 0.00
Solid Biosciences (SLDB) United States $0.332B 0.00
MeiraGTx Holdings (MGTX) United States $0.312B 0.00
Atea Pharmaceuticals (AVIR) United States $0.311B 0.00
Terns Pharmaceuticals (TERN) United States $0.307B 0.00
Ocugen (OCGN) United States $0.304B 0.00
Nautilus Biotechnology (NAUT) United States $0.300B 0.00
Ventyx Biosciences (VTYX) United States $0.299B 0.00
XOMA (XOMA) United States $0.298B 0.00
Kamada (KMDA) Israel $0.298B 22.52
CorMedix Inc (CRMD) United States $0.292B 0.00
Contineum Therapeutics (CTNM) United States $0.291B 0.00
Erasca (ERAS) United States $0.285B 0.00
Renovaro (RENB) United States $0.283B 0.00
Anavex Life Sciences (AVXL) United States $0.280B 0.00
Werewolf Therapeutics (HOWL) United States $0.277B 0.00
Rapt Therapeutics (RAPT) United States $0.275B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.274B 0.00
Inozyme Pharma (INZY) United States $0.272B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.262B 91.20
Oxford BioMedica (OXBDF) United Kingdom $0.262B 0.00
ChromaDex (CDXC) United States $0.256B 0.00
Invivyd (IVVD) United States $0.254B 0.00
XBiotech (XBIT) United States $0.246B 0.00
Inovio Pharmaceuticals (INO) United States $0.237B 0.00
Verastem (VSTM) United States $0.236B 0.00
AC Immune (ACIU) Switzerland $0.234B 0.00
Puma Biotechnology (PBYI) United States $0.233B 10.50
Coherus BioSciences (CHRS) United States $0.229B 0.00
Prima BioMed (IMMP) Australia $0.228B 0.00
23andMe Holding (ME) United States $0.226B 0.00
Ovid Therapeutics (OVID) United States $0.223B 0.00
2seventy Bio (TSVT) United States $0.219B 0.00
UniQure (QURE) Netherlands $0.218B 0.00
Sutro Biopharma (STRO) United States $0.217B 0.00
X4 Pharmaceuticals (XFOR) United States $0.217B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.214B 0.00
Adverum Biotechnologies (ADVM) United States $0.211B 0.00
G1 Therapeutics (GTHX) United States $0.208B 0.00
Design Therapeutics (DSGN) United States $0.206B 0.00
Compass Therapeutics (CMPX) United States $0.204B 0.00
Opthea (OPT) Australia $0.200B 0.00
Poseida Therapeutics (PSTX) United States $0.200B 0.00
Innate Pharma S.A (IPHA) France $0.199B 0.00
Codexis (CDXS) United States $0.197B 0.00
INmune Bio (INMB) United States $0.193B 0.00
Lifecore Biomedical (LFCR) United States $0.192B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.191B 0.00
Alimera Sciences (ALIM) United States $0.190B 0.00
Elevation Oncology (ELEV) United States $0.189B 0.00
Akoya Biosciences (AKYA) United States $0.188B 0.00
Cardiff Oncology (CRDF) United States $0.187B 0.00
Trevi Therapeutics (TRVI) United States $0.183B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.179B 0.00
Candel Therapeutics (CADL) United States $0.178B 0.00
Kodiak Sciences (KOD) United States $0.178B 0.00
GENFIT S.A (GNFT) France $0.174B 0.00
Inventiva S.A (IVA) France $0.170B 0.00
Adocia (ADOCY) France $0.169B 0.00
Compugen (CGEN) Israel $0.165B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.164B 0.00
Greenwich LifeSciences (GLSI) United States $0.163B 0.00
ScPharmaceuticals (SCPH) United States $0.162B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.160B 0.00
Gossamer Bio (GOSS) United States $0.160B 0.00
Skye Bioscience (SKYE) United States $0.159B 0.00
Agenus (AGEN) United States $0.155B 0.00
Adicet Bio (ACET) United States $0.154B 0.00
BioStem Technologies (BSEM) $0.152B 0.00
CervoMed (CRVO) United States $0.152B 0.00
I-Mab (IMAB) China $0.146B 0.00
Zura Bio (ZURA) United States $0.143B 0.00
Scilex Holding (SCLX) United States $0.141B 0.00
Molecular Partners AG (MOLN) Switzerland $0.141B 0.00
Annovis Bio (ANVS) United States $0.140B 0.00
Cellectis S.A (CLLS) France $0.139B 0.00
Syros Pharmaceuticals (SYRS) United States $0.136B 0.00
DBV Technologies S.A (DBVT) France $0.133B 0.00
Sagimet Biosciences (SGMT) United States $0.133B 0.00
Omega Therapeutics (OMGA) United States $0.129B 0.00
VistaGen Therapeutics (VTGN) United States $0.128B 0.00
Coya Therapeutics (COYA) United States $0.123B 0.00
Repare Therapeutics (RPTX) Canada $0.122B 0.00
Adagene (ADAG) China $0.121B 0.00
Nuvectis Pharma (NVCT) United States $0.119B 0.00
PDS Biotechnology (PDSB) United States $0.119B 0.00
Vor Biopharma (VOR) $0.119B 0.00
Rezolute (RZLT) United States $0.116B 0.00
Seer (SEER) United States $0.115B 0.00
Emergent Biosolutions (EBS) United States $0.114B 0.00
BioAtla (BCAB) United States $0.113B 0.00
Cartesian Therapeutics (RNAC) United States $0.112B 0.00
Immunic (IMUX) United States $0.112B 0.00
CytomX Therapeutics (CTMX) United States $0.110B 0.00
Seres Therapeutics (MCRB) United States $0.110B 0.00
TELA Bio (TELA) United States $0.110B 0.00
ATyr Pharma (LIFE) United States $0.109B 0.00
Oncobiologics (OTLK) United States $0.107B 0.00
BioHarvest Sciences (CNVCF) Canada $0.105B 0.00
Vigil Neuroscience (VIGL) United States $0.104B 0.00
Sangamo Therapeutics (SGMO) United States $0.102B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.101B 0.00
Bluebird Bio (BLUE) United States $0.101B 0.00
BioXcel Therapeutics (BTAI) United States $0.100B 0.00
Clearside Biomedical (CLSD) United States $0.100B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.098B 0.00
IO Biotech (IOBT) Denmark $0.096B 0.00
Elicio Therapeutics (ELTX) United States $0.095B 0.00
BeyondSpring (BYSI) United States $0.095B 0.00
DiaMedica Therapeutics (DMAC) United States $0.093B 0.00
Genelux (GNLX) United States $0.093B 0.00
Allakos (ALLK) United States $0.090B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.088B 0.00
Curis (CRIS) United States $0.087B 0.00
Abeona Therapeutics (ABEO) United States $0.087B 0.00
Galena Biopharma (SLS) United States $0.087B 0.00
Q32 Bio (QTTB) United States $0.087B 0.00
Atara Biotherapeutics (ATRA) United States $0.085B 0.00
Leap Therapeutics (LPTX) United States $0.084B 0.00
HOOKIPA Pharma (HOOK) United States $0.084B 0.00
Aileron Therapeutics (ALRN) United States $0.084B 0.00
Eton Pharmaceuticals (ETON) United States $0.082B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.081B 0.00
InflaRx (IFRX) Germany $0.080B 0.00
Oncolytics Biotech (ONCY) Canada $0.080B 0.00
Gritstone Bio (GRTS) United States $0.080B 0.00
Eupraxia Pharmaceuticals (EPRX) $0.080B 0.00
Cognition Therapeutics (CGTX) United States $0.078B 0.00
Athira Pharma (ATHA) United States $0.077B 0.00
VTv Therapeutics (VTVT) United States $0.077B 0.00
Spero Therapeutics (SPRO) United States $0.077B 2.84
Passage Bio (PASG) United States $0.076B 0.00
Connect Biopharma Holdings (CNTB) United States $0.075B 0.00
YS Biopharma (YS) China $0.075B 0.00
Affimed (AFMD) Germany $0.074B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.074B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.072B 0.00
AN2 Therapeutics (ANTX) United States $0.071B 0.00
Turnstone Biologics (TSBX) United States $0.071B 0.00
Elutia (ELUT) United States $0.070B 0.00
Alpha Teknova (TKNO) United States $0.070B 0.00
Instil Bio (TIL) United States $0.070B 0.00
Landos Biopharma (LABP) United States $0.069B 0.00
Cue Biopharma (CUE) United States $0.069B 0.00
Precision BioSciences (DTIL) United States $0.068B 0.00
MediciNova (MNOV) United States $0.066B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.066B 0.00
Celularity (CELU) United States $0.066B 0.00
Equillium (EQ) United States $0.063B 0.00
Aligos Therapeutics (ALGS) United States $0.063B 0.00
Ikena Oncology (IKNA) United States $0.062B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.062B 0.00
Rallybio (RLYB) United States $0.060B 0.00
Entera Bio (ENTX) Israel $0.060B 0.00
CalciMedica (CALC) United States $0.059B 0.00
Kezar Life Sciences (KZR) United States $0.058B 0.00
LENZ Therapeutics (LENZ) United States $0.058B 0.00
Lantern Pharma (LTRN) United States $0.058B 0.00
Kronos Bio (KRON) United States $0.058B 0.00
HCW Biologics (HCWB) United States $0.057B 0.00
Immix Biopharma (IMMX) United States $0.056B 0.00
Cidara Therapeutics (CDTX) United States $0.056B 0.00
Intensity Therapeutics (INTS) United States $0.055B 0.00
Enzo Biochem (ENZ) United States $0.054B 0.00
AVROBIO (AVRO) United States $0.053B 0.00
ARCA Biopharma (ABIO) United States $0.053B 0.00
Checkpoint Therapeutics (CKPT) United States $0.051B 0.00
Ocean Biomedical (OCEA) United States $0.049B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.049B 0.00
Genenta Science S.p.A (GNTA) Italy $0.046B 0.00
Beyond Air (XAIR) United States $0.046B 0.00
Quince Therapeutics (QNCX) United States $0.046B 0.00
Bolt Biotherapeutics (BOLT) United States $0.046B 0.00
Immuneering (IMRX) United States $0.044B 0.00
Prenetics Global (PRE) Cayman Islands $0.044B 0.00
Aadi Bioscience (AADI) United States $0.044B 0.00
Dyadic (DYAI) United States $0.043B 0.00
Clene (CLNN) United States $0.043B 0.00
Bionano Genomics (BNGO) United States $0.042B 0.00
Apollomics (APLM) United States $0.041B 0.00
Estrella Immunopharma (ESLA) United States $0.041B 0.00
OKYO Pharma (OKYO) $0.041B 0.00
SAB Biotherapeutics (SABS) United States $0.041B 0.00
NextCure (NXTC) United States $0.040B 0.00
NKGen Biotech (NKGN) United States $0.039B 0.00
Carmell (CTCX) United States $0.039B 0.00
Ocuphire Pharma (OCUP) United States $0.038B 0.00
Cyclo Therapeutics (CYTH) United States $0.037B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.037B 0.00
Promis Neurosciences (PMN) Canada $0.037B 0.00
Cara Therapeutics (CARA) United States $0.037B 0.00
Xilio Therapeutics (XLO) United States $0.037B 0.00
BRIACELL THERAP (BCTX) Canada $0.035B 0.00
Fortress Biotech (FBIO) United States $0.034B 0.00
IN8bio (INAB) United States $0.034B 0.00
Theratechnologies (THTX) Canada $0.033B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.032B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.031B 0.00
MiNK Therapeutics (INKT) United States $0.031B 0.00
Femasys (FEMY) United States $0.029B 0.00
Spruce Biosciences (SPRB) United States $0.029B 0.00
Dare Bioscience (DARE) United States $0.029B 0.00
Lexaria Bioscience (LEXX) Canada $0.028B 0.00
BioAffinity Technologies (BIAF) United States $0.028B 0.00
Aprea Therapeutics (APRE) United States $0.028B 0.00
Eyenovia (EYEN) United States $0.028B 0.00
Evogene (EVGN) Israel $0.028B 0.00
Pluri (PLUR) Israel $0.026B 0.00
Forte Biosciences (FBRX) United States $0.026B 0.00
Sensei Biotherapeutics (SNSE) United States $0.025B 0.00
UNITY Biotechnology (UBX) United States $0.025B 0.00
Semper Paratus Acquisition (TVGN) United States $0.024B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.024B 0.00
Lisata Therapeutics (LSTA) United States $0.024B 0.00
Lumos Pharma (LUMO) United States $0.023B 0.00
Biora Therapeutics (BIOR) United States $0.022B 0.00
Synlogic (SYBX) United States $0.022B 0.00
Evaxion Biotech (EVAX) Denmark $0.022B 0.00
RenovoRx (RNXT) United States $0.020B 0.00
Vincerx Pharma (VINC) United States $0.020B 0.00
Aptose Biosciences (APTO) Canada $0.019B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.018B 0.00
Galecto (GLTO) Denmark $0.018B 0.00
KALA BIO (KALA) United States $0.018B 0.00
Benitec Biopharma (BNTC) United States $0.017B 0.00
Orgenesis (ORGS) United States $0.017B 0.00
Vaxxinity (VAXX) United States $0.017B 0.00
VBI Vaccines (VBIV) United States $0.017B 0.00
Talis Biomedical (TLIS) United States $0.017B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.016B 0.00
Cocrystal Pharma (COCP) United States $0.016B 0.00
ABVC BioPharma (ABVC) United States $0.016B 0.00
Aytu BioPharma (AYTU) United States $0.016B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.015B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.015B 0.00
IMMURON (IMRN) Australia $0.014B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
Purple Biotech (PPBT) Israel $0.013B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.013B 0.00
Senti Biosciences (SNTI) United States $0.013B 0.00
Imunon (IMNN) United States $0.012B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.012B 0.00
Monopar Therapeutics (MNPR) United States $0.011B 0.00
Prana Biotechnology (ATHE) Australia $0.011B 0.00
Elevai Labs (ELAB) United States $0.010B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Organovo Holdings (ONVO) United States $0.010B 0.00
Galera Therapeutics (GRTX) United States $0.010B 0.00
Moleculin Biotech (MBRX) United States $0.010B 0.00
Telesis Bio (TBIO) United States $0.010B 0.00
AEterna Zentaris (AEZS) Canada $0.010B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.009B 0.00
Eterna Therapeutics (ERNA) United States $0.009B 0.00
Genetic Technologies (GENE) Australia $0.009B 0.00
Biorestorative Therapies (BRTX) United States $0.009B 0.00
Biofrontera (BFRI) United States $0.008B 0.00
Virios Therapeutics (VIRI) United States $0.008B 0.00
NuCana (NCNA) United Kingdom $0.008B 0.00
Bionomics (BNOX) Australia $0.008B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.008B 0.00
TFF Pharmaceuticals (TFFP) United States $0.008B 0.00
Cyclerion Therapeutics (CYCN) United States $0.008B 0.00
Chemomab Therapeutics (CMMB) Israel $0.007B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.007B 0.00
Pulmatrix (PULM) United States $0.007B 0.00
Atrinsic (PTIX) United States $0.007B 0.00
Pasithea Therapeutics (KTTA) United States $0.007B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.007B 0.00
AquaBounty Technologies (AQB) United States $0.007B 0.00
Psyence Biomedical (PBM) United States $0.007B 0.00
Trevena (TRVN) United States $0.007B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
Cadrenal Therapeutics (CVKD) United States $0.007B 0.00
EFFECTOR Therapeutics (EFTR) United States $0.007B 0.00
Enveric Biosciences (ENVB) United States $0.007B 0.00
Kineta (KA) United States $0.007B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
Novogen (KZIA) Australia $0.006B 0.00
Vaccinex (VCNX) United States $0.006B 0.00
First Wave BioPharma (FWBI) United States $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.006B 0.00
Palisade Bio (PALI) United States $0.005B 0.00
Kintara Therapeutics (KTRA) United States $0.005B 0.00
Silo Pharma (SILO) United States $0.005B 0.00
PaxMedica (PXMD) United States $0.005B 0.00
GT Biopharma (GTBP) United States $0.005B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
Alzamend Neuro (ALZN) United States $0.005B 0.00
Bright Minds Biosciences (DRUG) United States $0.005B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.005B 0.00
NexImmune (NEXI) United States $0.004B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.004B 0.00
Portage Biotech (PRTG) $0.004B 0.00
Exicure (XCUR) United States $0.004B 0.31
Tharimmune (THAR) United States $0.004B 0.00
Cingulate (CING) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Longeveron (LGVN) United States $0.004B 0.00
TRACON Pharmaceuticals (TCON) United States $0.004B 0.00
GENPREX (GNPX) United States $0.004B 0.00
Seelos Therapeutics (SEEL) United States $0.004B 0.00
Ensysce Biosciences (ENSC) United States $0.004B 0.00
Soligenix (SNGX) United States $0.004B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.004B 0.00
Mustang Bio (MBIO) United States $0.004B 0.00
GeoVax Labs (GOVX) United States $0.004B 0.00
Biophytis SA (BPTS) France $0.003B 0.00
Revelation Biosciences (REVB) United States $0.003B 0.00
Invo BioScience (INVO) United States $0.003B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.003B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
ARAVIVE, INC (ARAV) United States $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
CNS Pharmaceuticals (CNSP) United States $0.002B 0.00
Notable Labs (NTBL) United States $0.002B 0.00
ThermoGenesis Holdings (THMO) United States $0.002B 0.00
NeuBase Therapeutics (NBSE) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.001B 0.00
GRI Bio (GRI) United States $0.001B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.001B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
Sunshine Biopharma (SBFM) United States $0.001B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.001B 0.00
Bone Biologics (BBLG) United States $0.001B 0.00
Allarity Therapeutics (ALLR) United States $0.000B 0.00
Aptevo Therapeutics (APVO) United States $0.000B 0.00
Sinovac Biotech (SVA) China $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00